Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Finasteride helps induce ovulation in nonresponder PCOS women.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

PCOS increases the risk of heart disease and type 2 diabetes in women.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.